Laboratory of Genetics and Metabolism, Maternal and Child Health Hospital of Guangxi Zhuang Autonomous Region, Nanning.
Department of Prenatal Diagnostic Center, Guangzhou Women and Children's Medical Centre, Guangzhou Medical University, Guangzhou, People's Republic of China.
Blood Coagul Fibrinolysis. 2020 Dec;31(8):506-510. doi: 10.1097/MBC.0000000000000952.
: Hemophilia A is an X-linked hemorrhagic disorder caused by deficiency or dysfunction of the coagulation factor VIII (FVIII), and a great variety of mutations in the factor VIII gene (F8) are identified. We aimed to identify the genetic defects of the F8 gene in a Chinese patient with moderate hemophilia A. We have identified a novel intronic variant in the hemophilia A patient by DNA sequence analysis, cDNA sequencing, and TA clone sequencing. An intronic variant, c.5816-1G>A, was identified and the cDNA sequencing confirmed the pathogenicity of the transition. TA clone sequencing showed that the splicing mutation produced two aberrant premRNA skipping exons (18 and exon 18 + 19, respectively). These aberrant mRNA forms maintain the reading frame and are predicted to code for deleted FVIII isoforms and the shorter abnormal transcript accounted for one-eighth of the total mRNA. There was a new unreported transcript with E22 spliced out in healthy individuals and our patient, whose specific functions need to be determined in further studies. Our study widens the mutation spectrum of the F8 gene. In addition, the study findings could provide the opportunity to reveal alternative splicing patterns.
血友病 A 是一种 X 连锁出血性疾病,由凝血因子 VIII(FVIII)缺乏或功能障碍引起,已鉴定出 F8 基因(F8)的多种突变。我们旨在通过 DNA 序列分析、cDNA 测序和 TA 克隆测序鉴定中国中度血友病 A 患者的 F8 基因遗传缺陷。通过 DNA 序列分析、cDNA 测序和 TA 克隆测序,在血友病 A 患者中鉴定出一个新的内含子变异。cDNA 测序证实了该转换的致病性。TA 克隆测序显示剪接突变产生了两个异常的前 mRNA 外显子跳跃(分别为 18 和外显子 18+19)。这些异常的 mRNA 形式保持阅读框,并预测编码缺失的 FVIII 同种型和较短的异常转录本占总 mRNA 的八分之一。在健康个体和我们的患者中存在一种新的未报道的 E22 剪接缺失的转录本,其具体功能需要在进一步的研究中确定。本研究拓宽了 F8 基因的突变谱。此外,研究结果还为揭示替代剪接模式提供了机会。